Search Results 451-460 of 16817 for ESCITALOPRAM+OXALATE
Study CC-90002-AML-001 is an open-label, Phase 1 dose escalation (Part A) and expansion (Part B), clinical study of CC-90002, administered by intravenous (IV) ...
Search tips. Browsing versus searching. The browse feature of the website relies on the categorization of trials by diseases and conditions or procedures.
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
Abrocitinib is used to treat moderate to severe atopic dermatitis (eczema) in patients who have taken other medicines that did not work well and whose condition ...
Participation in the MRI study is optional. Participants will undergo a standardized brain MRI protocol including susceptibility-weighted or gradient-echo T2*- ...
The purpose of this study is to collect surgically removed atrial tissue for genetic, pathologic, metabolic, and molecular studies in patients with or without a ...
[MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.
... 10 mg prednisone. Dexamethasone 4 mg iv with chemotherapy to prevent nausea is allowed;; RANKL infusion: Concurrent denosumab (which binds the cytokine RANKL) ...
You can master healthy eating by learning how to plan meals and shop smart, and by practicing healthy-cooking techniques.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!